{"i": ["indacaterol"], "o": []}
{"i": [], "o": []}
{"i": ["Indacaterol"], "o": []}
{"i": ["\u03b22 - agonist"], "o": []}
{"i": ["indacaterol", "placebo"], "o": ["efficacy , safety , and tolerability"]}
{"i": [], "o": ["FEV1"]}
{"i": [], "o": ["adverse events ( AEs ), mean serum potassium and blood glucose , QTc ( Fridericia ), and vital signs ."]}
{"i": ["indacaterol"], "o": []}
{"i": ["placebo"], "o": []}
{"i": ["indacaterol", "placebo"], "o": ["Trough FEV1"]}
{"i": ["indacaterol", "placebo"], "o": ["Trough FEV1"]}
{"i": ["indacaterol - placebo", "Indacaterol", "placebo"], "o": ["peak FEV1"]}
{"i": ["indacaterol", "placebo"], "o": ["AUC measurements for FEV1"]}
{"i": ["Indacaterol", "placebo"], "o": ["percentage of days of poor control", "use of rescue medication"]}
{"i": ["indacaterol", "placebo"], "o": ["AEs", "COPD worsening"]}
{"i": ["placebo"], "o": []}
{"i": [], "o": ["QTc", "Serum potassium and blood glucose levels"]}
{"i": ["Indacaterol"], "o": []}
{"i": ["placebo"], "o": ["bronchodilation", "safety and tolerability profile", "rescue medication use"]}
{"i": ["Indacaterol"], "o": []}
{"i": ["\u03b22 - agonist"], "o": []}
{"i": ["indacaterol", "placebo"], "o": ["efficacy , safety , and tolerability"]}
{"i": [], "o": ["FEV1"]}
{"i": [], "o": ["adverse events ( AEs ), mean serum potassium and blood glucose , QTc ( Fridericia ), and vital signs ."]}
{"i": ["indacaterol"], "o": []}
{"i": ["placebo"], "o": []}
{"i": ["indacaterol", "placebo"], "o": ["Trough FEV1"]}
{"i": ["indacaterol", "placebo"], "o": ["Trough FEV1"]}
{"i": ["indacaterol - placebo", "Indacaterol", "placebo"], "o": ["peak FEV1"]}
{"i": ["indacaterol", "placebo"], "o": ["AUC measurements for FEV1"]}
{"i": ["Indacaterol", "placebo"], "o": ["percentage of days of poor control", "use of rescue medication"]}
{"i": ["indacaterol", "placebo"], "o": ["AEs", "COPD worsening"]}
{"i": ["placebo"], "o": []}
{"i": [], "o": ["QTc", "Serum potassium and blood glucose levels"]}
{"i": ["Indacaterol"], "o": []}
{"i": ["placebo"], "o": ["bronchodilation", "safety and tolerability profile", "rescue medication use"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["salmeterol and formoterol"], "o": []}
{"i": [], "o": []}
{"i": ["Indacaterol"], "o": []}
{"i": ["LABA"], "o": []}
{"i": ["salmeterol", "Indacaterol", "formoterol"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["cardiovascular safety profile"]}
{"i": ["indacaterol"], "o": []}
{"i": [], "o": ["overall safety and tolerability profile"]}
{"i": ["indacaterol"], "o": ["efficacy and safety"]}
{"i": [], "o": []}
{"i": ["placebo - controlled"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["salbutamol ."], "o": ["forced expiratory volume in 1 s ( FEV1 )", "FEV1 / forced vital capacity ( FVC )"]}
{"i": [], "o": []}
{"i": ["short - acting anticholinergics", "short - acting \u03b22 - agonists", "long - acting anticholinergic agents", "fixed - dose combination ( FDC ) of a \u03b22 - agonist and an inhaled corticosteroid ( ICS )", "other LABAs", "FDC of a short - acting \u03b22 - agonist and a short - acting anticholinergic"], "o": []}
{"i": [], "o": []}
{"i": ["ICS", "\u03b22 - agonist"], "o": []}
{"i": ["indacaterol"], "o": []}
{"i": ["matching placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["Salbutamol"], "o": []}
{"i": ["ICS monotherapy", "ICS or FDC"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["FEV1"]}
{"i": [], "o": ["FEV1"]}
{"i": [], "o": ["Trough FEV1"]}
{"i": [], "o": []}
{"i": [], "o": ["morning and evening peak expiratory flow ( PEF", "daily clinical symptoms , rescue salbutamol use , any change in concomitant medications , and adverse events ( AEs )."]}
{"i": [], "o": []}
{"i": [], "o": ["AEs and serious AEs ( SAEs ) and monitoring of haematology and blood chemistry ( including serum potassium and blood glucose ), vital signs , and electrocardiograms including QTc interval"]}
{"i": [], "o": ["dyspnoea , cough , sputum purulence or volume , or wheeze"]}
{"i": [], "o": ["FEV1"]}
{"i": [], "o": ["standardised area under the curve ( AUC ) for FEV1", "peak FEV1", "trough FEV1", "point FEV1"]}
{"i": [], "o": []}
{"i": [], "o": ["cough , wheeze , production of sputum , colour of sputum , and breathlessness ).", "number of ' days of poor control ',", "use of rescue medication , PEF"]}
{"i": [], "o": []}
{"i": ["indacaterol", "placebo"], "o": ["FEV1"]}
{"i": ["formoterol"], "o": ["FEV1"]}
{"i": ["indacaterol", "placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["FEV1 and FEV1 reversibility"]}
{"i": [], "o": []}
{"i": ["indacaterol", "placebo"], "o": []}
{"i": [], "o": []}
{"i": ["indacaterol", "placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["mean duration of COPD"]}
{"i": ["Indacaterol"], "o": []}
{"i": ["Placebo"], "o": []}
{"i": ["salbutamol"], "o": []}
{"i": ["indacaterol", "placebo"], "o": ["Mean patient exposures", "compliance"]}
{"i": ["indacaterol - placebo", "indacaterol", "placebo"], "o": ["bronchodilator efficacy", "FEV1"]}
{"i": ["Indacaterol", "placebo"], "o": ["FEV1"]}
{"i": ["indacaterol - placebo"], "o": []}
{"i": [], "o": ["FEV1"]}
{"i": ["indacaterol", "placebo"], "o": ["FEV1"]}
{"i": ["indacaterol - placebo"], "o": []}
{"i": ["Indacaterol"], "o": []}
{"i": ["indacaterol - placebo", "placebo"], "o": ["peak FEV1"]}
{"i": ["indacaterol", "placebo"], "o": ["standardised AUC measurements for FEV1"]}
{"i": ["Indacaterol"], "o": []}
{"i": ["Indacaterol", "Placebo"], "o": []}
{"i": ["Indacaterol", "Placebo"], "o": []}
{"i": ["Placebo"], "o": []}
{"i": [], "o": []}
{"i": ["indacaterol", "placebo"], "o": ["morning and evening PEF"]}
{"i": ["indacaterol"], "o": []}
{"i": ["placebo"], "o": ["rescue medication", "daytime , and night - time number of puffs of rescue medication", "days with no rescue use"]}
{"i": ["indacaterol"], "o": ["percentage of COPD ' days of poor control '"]}
{"i": ["placebo"], "o": []}
{"i": ["Indacaterol"], "o": ["percentage of COPD ' days of poor control", "Rescue medication use", "mean daily number of puffs of rescue medication"]}
{"i": ["Indacaterol", "Placebo"], "o": ["day time number of puffs of rescue medication"]}
{"i": ["Indacaterol", "Placebo"], "o": ["mean night time number of puffs of rescue medication"]}
{"i": ["Indacaterol", "Placebo"], "o": []}
{"i": ["Indacaterol", "Placebo"], "o": []}
{"i": ["Placebo"], "o": []}
{"i": [], "o": ["overall rate of AEs"]}
{"i": ["indacaterol", "placebo"], "o": ["cough", "COPD worsening"]}
{"i": ["indacaterol", "placebo"], "o": ["muscle spasm , headache , and tremor )"]}
{"i": ["indacaterol", "placebo"], "o": ["severe AEs"]}
{"i": ["indacaterol", "placebo"], "o": ["AEs"]}
{"i": ["placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["cardiac arrhythmia"]}
{"i": [], "o": []}
{"i": ["Indacaterol"], "o": ["COPD exacerbations"]}
{"i": ["Placebo"], "o": []}
{"i": ["indacaterol", "placebo ."], "o": []}
{"i": [], "o": ["onset of cough", "cough and bronchospasm ."]}
{"i": [], "o": ["discontinuation rates ."]}
{"i": ["indacaterol", "placebo"], "o": ["blood glucose and serum potassium"]}
{"i": ["indacaterol", "placebo"], "o": ["proportion of patients with clinically notable hyperglycaemia", "clinically notable low potassium value"]}
{"i": ["indacaterol", "placebo"], "o": ["pulse rate", "maximum post - baseline pulse rate"]}
{"i": ["indacaterol", "placebo"], "o": ["maximum post - baseline diastolic blood pressure", "maximum post - baseline systolic blood pressure"]}
{"i": ["indacaterol", "placebo"], "o": ["notable maximum post - baseline QTc interval"]}
{"i": [], "o": ["QTc interval", "QTc interval ( Fridericia ' s )"]}
{"i": ["indacaterol"], "o": []}
{"i": [], "o": []}
{"i": ["indacaterol"], "o": ["bronchodilation"]}
{"i": ["placebo"], "o": ["Trough FEV1"]}
{"i": [], "o": []}
{"i": ["indacaterol", "placebo"], "o": ["FEV1", "FEV1 AUCs"]}
{"i": ["indacaterol"], "o": []}
{"i": [], "o": []}
{"i": ["indacaterol", "formoterol"], "o": []}
{"i": [], "o": []}
{"i": ["LABAs", "salmeterol"], "o": []}
{"i": ["indacaterol - placebo", "indacaterol"], "o": ["efficacy"]}
{"i": ["indacaterol"], "o": ["efficacy"]}
{"i": ["indacaterol", "placebo"], "o": ["trough FEV1"]}
{"i": ["indacaterol"], "o": []}
{"i": ["placebo"], "o": ["bronchodilation"]}
{"i": [], "o": []}
{"i": ["indacaterol"], "o": []}
{"i": ["indacaterol", "placebo"], "o": ["requirement for rescue medication .", "FEV1", "morning and evening PEF"]}
{"i": [], "o": []}
{"i": ["indacaterol"], "o": ["rescue medication use"]}
{"i": ["Indacaterol"], "o": []}
{"i": [], "o": ["drop - out rate"]}
{"i": ["indacaterol", "placebo"], "o": ["incidence of AEs"]}
{"i": ["indacaterol", "placebo"], "o": ["COPD worsening and cough"]}
{"i": [], "o": ["cough"]}
{"i": [], "o": ["class - related side effects", "hyperglycaemia , hypokalaemia , or prolonged QTc interval )"]}
{"i": [], "o": ["low potassium value"]}
{"i": ["indacaterol", "placebo"], "o": ["clinically notable hyperglycaemia"]}
{"i": ["indacaterol"], "o": ["absolute QTc interval ( Fridericia ' s )", "cardiovascular incidents", "adverse cardiovascular effects", "Cardiac safety", "QTc"]}
{"i": [], "o": []}
{"i": ["Indacaterol"], "o": []}
{"i": ["placebo"], "o": ["bronchodilation", "rescue medication use"]}
{"i": ["indacaterol"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["INdacaterol"], "o": []}
{"i": [], "o": []}
